WO2007010504A3 - Acid addition salts of isoindoles acting as adrenergic receptor antagonists - Google Patents

Acid addition salts of isoindoles acting as adrenergic receptor antagonists Download PDF

Info

Publication number
WO2007010504A3
WO2007010504A3 PCT/IB2006/052516 IB2006052516W WO2007010504A3 WO 2007010504 A3 WO2007010504 A3 WO 2007010504A3 IB 2006052516 W IB2006052516 W IB 2006052516W WO 2007010504 A3 WO2007010504 A3 WO 2007010504A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid addition
addition salts
isoindoles
acting
receptor antagonists
Prior art date
Application number
PCT/IB2006/052516
Other languages
French (fr)
Other versions
WO2007010504A2 (en
Inventor
Pakala Kumara Savithru Sarma
Gyan Chand Yadav
Harish Niranjan Lal Dorwal
Praful Gupta
Original Assignee
Ranbaxy Lab Ltd
Pakala Kumara Savithru Sarma
Gyan Chand Yadav
Harish Niranjan Lal Dorwal
Praful Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Pakala Kumara Savithru Sarma, Gyan Chand Yadav, Harish Niranjan Lal Dorwal, Praful Gupta filed Critical Ranbaxy Lab Ltd
Publication of WO2007010504A2 publication Critical patent/WO2007010504A2/en
Publication of WO2007010504A3 publication Critical patent/WO2007010504A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Provided herein are acid addition salts of compounds of Formula (I). The acid addition salts of Formula I described herein can be used to treat benign prostatic hyperplasia (BPH) and the related symptoms thereof. Further, these compounds can be used to treat lower urinary tract symptoms (LUTS) that may or may not be associated with BPH. Process for preparing the compounds described herein, pharmaceutical compositions thereof, and the methods of treating BPH or related symptoms thereof and LUTS that may or may not be associated with BPH are also provided.
PCT/IB2006/052516 2005-07-22 2006-07-21 Acid addition salts of isoindoles acting as adrenergic receptor antagonists WO2007010504A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1940/DEL/2005 2005-07-22
IN1940DE2005 2005-07-22

Publications (2)

Publication Number Publication Date
WO2007010504A2 WO2007010504A2 (en) 2007-01-25
WO2007010504A3 true WO2007010504A3 (en) 2007-04-05

Family

ID=37517191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/052516 WO2007010504A2 (en) 2005-07-22 2006-07-21 Acid addition salts of isoindoles acting as adrenergic receptor antagonists

Country Status (1)

Country Link
WO (1) WO2007010504A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936661A (en) * 1982-08-26 1984-02-28 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and drug containing the same
WO2003084928A1 (en) * 2002-04-08 2003-10-16 Ranbaxy Laboratories Limited Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
WO2005037282A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936661A (en) * 1982-08-26 1984-02-28 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and drug containing the same
WO2003084928A1 (en) * 2002-04-08 2003-10-16 Ranbaxy Laboratories Limited Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
WO2005037282A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione

Also Published As

Publication number Publication date
WO2007010504A2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
MX2010007392A (en) Trpa1 antagonists.
WO2007095223A3 (en) Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
MX2010004244A (en) Organic compounds.
WO2006044497A3 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease
WO2008046083A3 (en) Use of oxindole compounds as therapeutic agents
MX2010007391A (en) Trpa1 antagonists.
WO2007011833A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008063202A3 (en) Heterobicyclic thiophene compounds for the treatment of cancer
WO2008064351A3 (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
WO2010011772A3 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
WO2010036998A3 (en) Indole and indoline derivatives and methods of use thereof
WO2007070434A3 (en) Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
WO2007106469A3 (en) Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
HK1113569A1 (en) Pyrazolo
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006060182A3 (en) HIGHLY BRANCHED HK PEPTIDES AS EFFECTIVE CARRIERS OF siRNA
WO2007050587A3 (en) Therapeutic compositions and methods
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
WO2011008312A3 (en) Indole and indoline derivatives and methods of use thereof
WO2009133374A3 (en) Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid
WO2006102232A3 (en) Dosing regimes for trans-clomiphene
WO2008076949A3 (en) Quinazoline derivatives and methods of treatment
WO2007015923A8 (en) Benzimidazoles useful as inhibitors of protein kinases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06780172

Country of ref document: EP

Kind code of ref document: A2